|We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.|
The Company U.S. Microbics (ticker symbol: BUGS) has recently posted a profitable quarter. Company stated revenues for the next five years are expected to reach $100 million. Share price is just starting to move upwards. "Letters of Intent" by Fortune 500 Companies are "signed" and awaiting full production delivery of microbial-blend (bugs) from U.S. Microbics newly established California West Coast Fermentation Facility.
This Company has the ability to sell environmental assisting microbial product technology into just about any International business, qovernment, munincipalities, production facilities, agriculture, aqua-culture, oil fields, education, restaurants, golf course... facility. The Board of Advisor Directors read like a Who's Who of International Nobel Laureate prize winners. The technology is proprietary and covered by U.S. and foreign patents and the share float is small. Management seems to know where they are headed... volume is just starting to heat up as... is the share price and they appear to be meeting stated objectives. The microbial blend of "bugs" is being used to increase agricultural production output and diminish herbicides and pesticide use. This technology was also used to clean up the aftermath of the Gulf War oil spills..... The Company expects to reach a minimum $4 price level by September of this year. They are shareholder driven and are an S.E.C. fully reporting company. From their website:
"The Company mission is to profitably apply, develop, train, acquire,
protect, license, and transfer XyclonyX technologies consisting of
patents, knowledge, products, processes and people in the global
environmental, agriculture, and natural resource marketplace.
The Company's objective is to establish itself as a leading provider of environmental technology and products to companies on a worldwide basis by licensing its superior technology, which meets governmental
standards, is environmentally friendly, easy to manufacture and apply
and yields high profit for its licensees.
U.S. Microbics (USMX), [OTCBB: BUGS] is building an environmental
technology conglomerate which could have revenues over $100 Million in
the next five years. Using the proprietary microbial technology, patents and unique culture collection developed over 30 years, acquired through its wholly-owned technology subsidiary, XyclonyX, USMX believes it can build the foundation for the international commercialization of this previously successful technology. USMX is restarting a known valuable technology, using proprietary products and only needs capital, people and product distribution. Unlike other companies who need to develop a product or technology and find a market and customers to sell it to, USMX already has products that have been developed, have sold for millions of dollars, use advanced technology unavailable to other companies, and have a proven world-wide market with applications ranging from oil field cleanup to increased food production in third world countries. With existing Letters of Intent for its products and services, USMX is truly on the verge of releasing and capitalizing on an enormous amount of technology for beneficial use that can touch the lives of every person on earth."
6965 El Camino Real, Suite 105-279
General Information: email@example.com
Customer Support: firstname.lastname@example.org
|© 2022 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News|